Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapy.
Venugopalan
Veena
V
University of Kentucky HealthCare, 800 Rose St, Rm H110, Lexington, KY 40536-0293, USA.
Martin
Craig A
CA
D000081:Acetamides / Q000008:administration & dosage / Q000493:pharmacokinetics; D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001850:Bone Diseases, Infectious / Q000188:drug therapy*; D017576:Daptomycin / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D000069349:Linezolid; D008911:Minocycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy; D023303:Oxazolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics; D000078304:Tigecycline
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000078304:Tigecycline; D008911:Minocycline; D000069349:Linezolid; D017576:Daptomycin